SCHEMBL6568636

SCHEMBL6568636

O=C(Nc1ccccc1C(F)(F)F)Nc1cc(-c2nc3ccccc3s2)cc(Cl)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.49
NPSR1 Q6W5P4 1/20 0.49
GRIK1 P39086 1/20 0.46
TRPV1 Q8NER1 1/20 0.46
ALDH1A1 P00352 3/20 0.45
TSHR P16473 1/20 0.45
MAPT P10636 8/20 0.45
TP53 P04637 6/20 0.44
CTSD P07339 1/20 0.43
LMNA P02545 5/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
HPGD P15428 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4344400 0.90 KDM4E (0.47) KDM4ENPSR1ALDH1A1MAPTTP53
SCHEMBL4344397 0.87 CTSD (0.44) KDM4ENPSR1ALDH1A1MAPTTP53
SCHEMBL6566878 0.85 MAPT (0.53) KDM4EMAPTTP53MEN1KMT2A
SCHEMBL4344405 0.83 KDM4E (0.45) KDM4ENPSR1ALDH1A1MAPTTP53
SCHEMBL6526530 0.83 MAPT (0.51) KDM4EALDH1A1MAPTTP53LMNA
SCHEMBL4505884 0.82 TP53 (0.52) KDM4EALDH1A1MAPTTP53LMNA
SCHEMBL6524162 0.81 NAMPT (0.57) KDM4ENPSR1ALDH1A1MAPTTP53
SCHEMBL4347962 0.81 MAPT (0.48) KDM4EALDH1A1MAPTTP53LMNA
SCHEMBL6519124 0.80 MAPT (0.47) KDM4ETRPV1MAPTTP53LMNA
SCHEMBL6565522 0.78 RAB9A (0.56) KDM4EALDH1A1TSHRMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed